# EDGAR Filing Document

**Accession Number:** 0002074850
**File Stem:** 0000000000-25-008022
**Filing Date:** 2025-7
**Character Count:** 6690
**Document Hash:** fbc14088ac25a71030bc6c99cfdd4fc9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-008022.hdr.sgml**: 20260114

**ACCESSION NUMBER**: 0000000000-25-008022

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250730

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Spring Valley Acquisition Corp. III
- **CENTRAL INDEX KEY:** 0002074850
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-08181

**BUSINESS ADDRESS:**
- **STREET 1:** 2100 MCKINNEY AVE., SUITE 1675
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** 214-308-5230

**MAIL ADDRESS:**
- **STREET 1:** 2100 MCKINNEY AVE., SUITE 1675
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001104659-25-065853

## Text-Extract

```

                                                               July 30, 2025

Christopher Sorrells
Chief Executive Officer
Spring Valley Acquisition Corp. III
2100 McKinney Ave., Suite 1675
Dallas, TX 75201

        Re: Spring Valley Acquisition Corp. III
            Draft Registration Statement on Form S-1
            Submitted July 3, 2025
            CIK No. 0002074850
Dear Christopher Sorrells:

       We have reviewed your draft registration statement and have the
following comments.

       Please respond to this letter by providing the requested information and
either
submitting an amended draft registration statement or publicly filing your
registration
statement on EDGAR. If you do not believe a comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

      After reviewing the information you provide in response to this letter
and your
amended draft registration statement or filed registration statement, we may
have additional
comments.

Draft Registration Statement on Form S-1
Cover Page

1.     You state that your efforts to identify a prospective initial business
combination target
       will not be limited to a particular industry or sector. If true, please
also state, as you do
       on page 2, that you plan to identify, acquire, and operate a business in
the natural
       resources and decarbonization industries or otherwise advise.
2.     You state that you cannot guarantee that your securities will be
approved for listing on
       Nasdaq. Please clarify if this offering is contingent on Nasdaq listing.
3.     Please state the amount of compensation received or to be received for
each sponsor,
       sponsor affiliate, and promoter as you do on page 14 and provide a cross
reference to
       the related disclosure. See to Item 1602(a)(3) of Regulation S-K.
 July 30, 2025
Page 2

Proposed Business, page 2

4.     You state that your management team has also formed and co-sponsored
Spring
       Valley Acquisition Corp. II which completed its initial public offering
in October
       2022 and has extended its timeframe to consummate a business
transaction. Please
       state the date by which Spring Valley II must consummate a business
transaction, the
       level of redemptions Spring Valley II has experienced and state if the
time frame may
       continue to be extended. Further, please state the current trading price
and the
       industry in which Spring Valley II is searching for potential business
combination
       candidates.
Business Combination Criteria, page 9

5.     Please also include disclosure that the SPAC   s ability to identify and
evaluate a target
       company may be impacted by significant competition among other SPACs in
       pursuing business combination transaction candidates and that
significant competition
       may impact the attractiveness of the acquisition terms that the SPAC
will be able to
       negotiate.
Initial Business Combination, page 10

6.     You state that the company has up to 24 months, from the closing of this
offering, to
       consummate a de-SPAC transaction or such later time as provided for in
any
       amendment to your amended and restated memorandum and articles of
association (an
          Extension Period   ) and that you may seek shareholder approval for
such
       amendments. You also state that there are no limits on the number of
extensions you
       may seek but do not expect to extend the time frame beyond 36 months
from closing
       of this offering. Please clarify that when shareholders vote for such
extensions if there
       is set durations of time under each vote and whether there are any
conditions to the
       extensions such as payments of additional funds into the trust.
Sponsor Information, page 14

7.     You state that the managing member of the Sponsor is Christopher
Sorrells and that
       no other person has a direct or indirect interest in the sponsor. Please
also state that
       amount of interest Christopher Sorrells has in the sponsor. See Item
1603(a)(7) of
       Regulation S-K.
The Offering
Conflicts of Interest, page 38

8.     You state that Christopher Sorrells, your Chairman and Chief Executive
Officer, also
       serves as CEO of Spring Valley II which may lead to some conflicts of
interest. Given
       your disclosure on page 75 that you rely heavily on a small group of
       individuals including Christopher Sorrells and Jeff Schramm please also
discuss here
       that Jeff Schramm also serves as the Chief Financial Officer for the
sponsor of Spring
       Valley II.
 July 30, 2025
Page 3
Risk Factors
If we are deemed to be an investment company under the Investment Company
Act..., page
54

9.     Please revise to confirm that if your facts and circumstances change
over time, you
       will update your disclosure to reflect how those changes impact the risk
that you may
       be considered to be operating as an unregistered investment company.

        Please contact Christine Torney at 202-551-3652 or Daniel Gordon at
202-551-3486
if you have questions regarding comments on the financial statements and
related
matters. Please contact Doris Stacey Gama at 202-551-3188 or Chris Edwards at
202-551-
6761 with any other questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:   Jason Simon, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._